Iranian Heart Journal

Iranian Heart Journal

Relationship Between Left Ventricular Diastolic Dysfunction Echocardiographic Indices and SYNTAX Score in Triple-Vessel CAD: A Cross-Sectional Study

Document Type : Original Article

Authors
Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, IR Iran.
Abstract
Background: Whether left ventricular diastolic dysfunction (LVDD) relates to anatomic coronary disease burden remains uncertain. We examined the association between echocardiographic diastolic indices and the Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score among patients with triple-vessel coronary artery disease (CAD).
Methods: We performed an analytical cross-sectional study of 153 consecutive patients with angiographically confirmed triple-vessel disease at the Dr Heshmat Rasht Heart Training Center (Iran) from 2022 through 2023. Eligible patients had blood pressure below 140/90 mm Hg and preserved systolic function; standard exclusions applied. We recorded demographics and cardiac risk factors and measured diastolic indices (left ventricular ejection fraction, E/A, average E/e′, left atrial volume index, deceleration time, tricuspid regurgitation velocity, septal and lateral e′, and left ventricular end-diastolic volume index). Coronary complexity was graded by the SYNTAX score (≤ 22, low and > 22, high). We used χ2, t, and Mann–Whitney tests and logistic regression (adjusted for age and sex; secondarily for diabetes and hyperlipidemia).
Results: Of 153 patients, 68 (44.4%) had low SYNTAX scores and 85 (55.6%) had high SYNTAX scores. None of the diastolic echocardiographic parameters differed between SYNTAX score groups or were independently associated with high SYNTAX scores on multivariable analysis. In contrast, diabetes and hyperlipidemia were associated with high SYNTAX scores: diabetes adjusted odds ratio (aOR) 3.71 (95% CI, 1.84 to 7.50) and hyperlipidemia aOR 2.83 (95% CI, 1.31 to 6.10).
Conclusions: In patients with triple-vessel CAD, echocardiographic indices of LV diastolic function were not associated with anatomic disease complexity, whereas diabetes and hyperlipidemia were. Larger studies across a broader spectrum of LVDD severity are warranted. (Iranian Heart Journal 2026; 27(4): 6-15)
Keywords

1.         Tsai I-T, Wang C-P, Lu Y-C, Hung W-C, Wu C-C, Lu L-F, et al. The burden of major adverse cardiac events in patients with coronary artery disease. BMC cardiovascular disorders. 2017; 17(1):1.
2.         Loffi M, Piccolo R, Regazzoni V, Di Tano G, Moschini L, Robba D, et al. Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection. Open heart. 2020; 7(2):e001428.
3.         Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE, et al. European Society of Cardiology: cardiovascular disease statistics 2019. European heart journal. 2020; 41(1):12-85.
4.         Ralapanawa U, Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. Journal of epidemiology and global health. 2021; 11(2):169-77.
5.         Álvarez-Álvarez MM, Zanetti D, Carreras-Torres R, Moral P, Athanasiadis G. A survey of sub-Saharan gene flow into the Mediterranean at risk loci for coronary artery disease. European Journal of Human Genetics. 2017; 25(4):472-6.
6.         Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. Journal of cellular physiology. 2019; 234(10):16812-23.
7.         Kim EK, Hahn J-Y, Park TK, Lee JM, Song YB, Chang S-A, et al. Prognostic implications of diastolic dysfunction change in patients with coronary artery disease undergoing percutaneous coronary intervention. Circulation Journal. 2019; 83(9):1891-900.
8.         Cho D-H, Kim M-A, Choi J, Kim M-N, Park S-M, Kim H-L, et al. Sex differences in the relationship between left ventricular diastolic dysfunction and coronary artery disease: from the korean women's chest pain registry. Journal of Women's Health. 2018; 27(7):912-9.
9.         AlJaroudi WA, Thomas JD, Rodriguez LL, Jaber WA. Prognostic value of diastolic dysfunction: state of the art review. Cardiology in review. 2014; 22(2):79-90.
10.      Mansour MJ, Chammas E, Hamoui O, Honeine W, AlJaroudi W. Association between left ventricular diastolic dysfunction and subclinical coronary artery calcification. Echocardiography. 2020; 37(2):253-9.
11.      AlJaroudi W, Alraies MC, Halley C, Rodriguez L, Grimm RA, Thomas JD, et al. Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction. Circulation. 2012; 125(6):782-8.
12.      Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Journal of Echocardiography. 2016; 17(12):1321-60.
13.      Liu S, Moussa M, Wassef AW, Hiebert BM, Hussain F, Jassal DS. The utility of systolic and diastolic echocardiographic parameters for predicting coronary artery disease burden as defined by the SYNTAX score. Echocardiography. 2016; 33(1):14-22.
14.      Bouthoorn S, Valstar GB, Gohar A, den Ruijter HM, Reitsma HB, Hoes AW, et al. The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis. Diabetes and Vascular Disease Research. 2018; 15(6):477-93.
15.      Abalı G, Akpınar O, Nisanoğlu V, Ilgenli TF. Severity of coronary artery disease and echocardiographic parameters of ventricular diastolic function. Echocardiography. 2014; 31(7):809-13.
16.      Mukhopadhyay T, Gupta A, Biswas U, Majumdar B. Severity of coronary artery disease and echocardiographic parameters of ventricular diastolic function in patients with non-ST-elevation acute coronary syndrome. Int J Med Sci Public Health. 2019; 8(1):86-90.